. Schéma-régional-d, organisation des soins (SROS) Available from: http://www.ars.oceanindien .sante.fr/fileadmin, 2011.

F. Stoll-keller, Available from: http://udsmed.ustrasbg .fr/emed/courses/VIROLOGIE/document/Grippe_D1_2012.pdf?cidReq=VIROLO GIE 8 grippe en face, p.225, 2007.

J. Cohen, . Grog, A. Mosnier, I. Daviaud, and . Ecogrippe, combien coûte la grippe ? Available from: http://www.grog.org/documents Available from Available from: http://www.invs.sante.fr/Dossiers-thematiques/Maladies-infectieuses/Maladies-a- prevention-vaccinale/Grippe/Grippe-generalites/Point-sur-les-connaissances 12, Ecogrippe.pdf 10. Organisation Mondiale de la Santé. Influenza (Seasonal) [Internet]. OMS, 2006.

H. Conseil-de-la-santé-publique, H. Avis, . Grippe, J. Treanor, F. Hayden et al., Haut Conseil de la Santé Publique Avis relatif à la priorisation de l'utilisation des antiviraux en situation d'épidémie de grippe saisonnière Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial, JAMA. Feb Lancet Infect Dis Feb, vol.1428314, issue.2382, pp.1016-1040, 2000.

J. Dobson, R. Whitley, S. Pocock, and A. Monto, Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials, The Lancet, vol.385, issue.9979, 2015.
DOI : 10.1016/S0140-6736(14)62449-1

L. Kaiser, C. Wat, T. Mills, P. Mahoney, P. Ward et al., Impact of Oseltamivir Treatment on Influenza-Related Lower Respiratory Tract Complications and Hospitalizations, Archives of Internal Medicine, vol.163, issue.14, pp.1667-72, 2003.
DOI : 10.1001/archinte.163.14.1667

F. Aoki, M. Macleod, P. Paggiaro, O. Carewicz, A. Sawy et al., Early administration of oral oseltamivir increases the benefits of influenza treatment, Journal of Antimicrobial Chemotherapy, vol.51, issue.1
DOI : 10.1093/jac/dkg007

L. Canini, J. Conway, A. Perelson, and F. Carrat, Impact of Different Oseltamivir Regimens on Treating Influenza A Virus Infection and Resistance Emergence: Insights from a Modelling Study):e1003568. 21. Organisation Mondiale de la Santé. Note de synthèse de l'OMS concernant les vaccins antigrippaux ? novembre 2012, Recommandations vaccinales pour la grippe [Internet]. 2015 p. 11?2. Available from, pp.461-76, 2012.

B. Gauzere and A. P. , La pandémie de grippe espagnole de 1918-1919 à la Réunion, pp.1-8, 2014.

B. Gaüzère, F. Bussienne, B. Bouchet, J. Jabot, A. Roussiaux et al., Formes graves d'infection par le virus A(H1N1)v2009 à La Réunion en 2009 et en 2010, pp.97-104, 2011.

C. Gradel, B. Gaüzère, U. De-bordeaux, and I. , Etude des cas graves de grippe à virus A(H1N1)2009 à la Réunion en 2009-2010 expérience du Service de réanimation du Centre hospitalier Félix Guyon de Saint-Denis, 2011.

. Mar, . Available, L. Filleul, D. Polycarpe, and I. Cire-océan-indien, Surveillance de la grippe dans l'océan Indien Available from, p.2014, 2015.

N. Caillere, P. Vilain, E. Sevin, F. Sahridj, D. Polycarpe et al., « Koman i lé » : une population sentinelle à la Réunion Présentation du système de surveillance et premiers résultats, pp.2-5, 2014.

G. Milinovich, G. Williams, A. Clements, and W. Hu, Internet-based surveillance systems for monitoring emerging infectious diseases, The Lancet Infectious Diseases, vol.14, issue.2, 2014.
DOI : 10.1016/S1473-3099(13)70244-5

M. Feb, . Sante?, D. Sante?, . La-famille-et, . Des et al., Commission spe?cialiseéspe?cialiseé Maladies transmissibles, sur proposition du Comite? technique des vaccinations Avis de la stratégie vaccinale grippe à la Réunion en 2010 [Internet] Haut Conseil de la Santé Publique Available from: www.hcsp.fr/explore.cgi/hcspa20100625_stratvaccgrippe10reunion Direction de l'hospitalisation, et de l'organisation des soins, Sous-direction de l'organisation du syste? me de soins, Circulaire DHOS, vol.14, issue.2, pp.160-168, 2003.

E. Brottet, L. Filleul, B. Gauzere, D. Vandroux, E. Antok et al., Epidémie de grippe saisonnière à virus B à la Réunion en 2014, associée à de nombreuses formes sévères hospitalisées en réanimation, BVS. 2015 Juin, issue.27, pp.5-8

. Season, Exploring Disease Severity by Virus Type and Subtype, J Infect Dis Oct, vol.15208, issue.8, pp.1305-1319, 2013.

D. Mertz, T. Kim, J. Johnstone, P. Lam, M. Science et al., Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis, BMJ, vol.347, issue.aug23 1
DOI : 10.1136/bmj.f5061

P. Ayscue, E. Murray, T. Uyeki, J. Zipprich, K. Harriman et al., Influenzaassociated intensive-care unit admissions and deaths-California

H. Conseil-de-la-santé-publique-kostova, D. Reed, C. Finelli, L. Cheng, P. Gargiullo et al., Efficacité de la vaccination contre la grippe saisonnière chez les personnes âgées et les professionnels de santé, Influenza Illness and Hospitalizations Averted by Influenza Vaccination in the United States, 2005.

O. Plos, People with Heart Disease and Those Who Have Had a Stroke Are at High Risk of Developing Complications from Influenza (the Flu) -People at high risk -Seasonal Influenza Flu and People with Diabetes, Centers for Disease Control and Prevention, vol.8, issue.6, pp.66312-66350, 2013.

D. Lau, D. Eurich, S. Majumdar, A. Katz, and J. Johnson, Available from: http://www.cdc.gov/flu/diabetes/index.htm 40 Working-age adults with diabetes experience greater susceptibility to seasonal influenza: a population-based cohort study, People at high risk -Seasonal Influenza, pp.2014690-2014698

H. Conseil-de-la-santé-publique, Avis relatif à l'actualisation de la vaccination contre la grippe saisonnière dans certaines populations (femmes enceintes et personnes obèses) 2012 février. 42. Mounts AW. Risk factors for severe outcomes following 2009 Influenza A (H1N1) infection: A Global Pooled Analysis, Lancet Infect Dis, 2006.

G. Szabo, CONSEQUENCES OF ALCOHOL CONSUMPTION ON HOST DEFENCE, Alcohol and Alcoholism, vol.34, issue.6
DOI : 10.1093/alcalc/34.6.830

P. Zhang, G. Bagby, K. Happel, W. Summer, and S. Nelson, Pulmonary host defenses and alcohol Organisation Mondiale de la Santé Bilan de la saison grippale 2014 dans l'hémisphère Sud, Front Biosci J Virtual Libr, vol.789, issue.23, pp.1314-1344, 2002.

S. Su, S. Chaves, A. Perez, D. Mello, T. Kirley et al., Comparing Clinical Characteristics Between Hospitalized Adults With Laboratory-Confirmed Influenza A and B Virus Infection Données de couverture vaccinales en France Available from: http://www.invs.sante.fr/Dossiers-thematiques/Maladies- infectieuses/Maladies-a-prevention-vaccinale, Clin Infect Dis Jul, vol.1559, issue.2, pp.252-257, 2014.

M. Danhof-pont and H. De-jager, Hospital-based cluster randomised controlled trial to assess effects of a multi-faceted programme on influenza vaccine coverage among hospital healthcare workers and nosocomial influenza in the Netherlands, 2009.

J. Castilla, P. Godoy, Á. Domínguez, V. Martín, M. Delgado-rodríguez et al., Risk factors and effectiveness of preventive measures against influenza in the community. Influenza Other Respir Viruses, pp.177-83, 2013.

M. Schwarzinger, Déterminants de l'acceptation individuelle de la vaccination pandémique A(H1N1)2009 en population adulte française, BEH, 2010.

K. Boiron, T. Blanchon, E. Etude, R. Flicoteaux, S. Cortarenoda et al., acceptabilité du vaccin contre la grippe saisonnière dans la population générale. France; 2013. 75 p. 57 Low acceptability of A/H1N1 pandemic vaccination in French adult population: did public health policy fuel public dissonance? PloS One, pp.10199-58, 2010.

G. Herrera, M. Iwane, C. M. Brown, C. Gershman, K. Shupe et al., Flu Vaccine Effectiveness: Questions and Answers for Health Professionals [Internet] Available from: http://www.cdc.gov/flu/professionals/vaccination/effectivenessqa.htm 60 Available from: http://www.cdc.gov/flu/professionals/vaccination/effectiveness-studies.htm 61 Influenza vaccine effectiveness among 50-64-year-old persons during a season of poor antigenic match between vaccine and circulating influenza virus strains: Colorado, United States, Centers for Disease Control and Prevention Centers for Disease Control and Prevention. Seasonal Influenza Vaccine Effectiveness, vol.2825, issue.151, pp.2743-2751, 2003.

A. Monto, S. Ohmit, J. Petrie, E. Johnson, R. Truscon et al., Comparative Efficacy of Inactivated and Live Attenuated Influenza Vaccines, New England Journal of Medicine, vol.361, issue.13, pp.1260-1267, 2009.
DOI : 10.1056/NEJMoa0808652

J. Beran, T. Vesikari, V. Wertzova, A. Karvonen, K. Honegr et al., Efficacy of Inactivated Split???Virus Influenza Vaccine against Culture???Confirmed Influenza in Healthy Adults: A Prospective, Randomized, Placebo???Controlled Trial, The Journal of Infectious Diseases, vol.200, issue.12, 2009.
DOI : 10.1086/648406

M. Osterholm, N. Kelley, A. Sommer, and E. Belongia, Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis, The Lancet Infectious Diseases, vol.12, issue.1, 2012.
DOI : 10.1016/S1473-3099(11)70295-X

M. Darvishian, G. Gefenaite, R. Turner, P. Pechlivanoglou, W. Van-der-hoek et al., After adjusting for bias in meta-analysis seasonal influenza vaccine remains effective in community-dwelling elderly, Journal of Clinical Epidemiology, vol.67, issue.7, pp.734-778
DOI : 10.1016/j.jclinepi.2014.02.009

L. Fressard, F. Collange, A. Gautier, C. Jestin, and O. Launay, Le médecin généraliste, premier acteur de la prévention et de la promotion de la santé [Internet]. 2014 Available from: http://www.socialsante .gouv.fr Vaccine Hesitancy Among General Practitioners and Its Determinants During Controversies: A National Cross-sectional Survey, 2015.

O. Régional-de and L. Santé, Institut national de prévention et d'éducation à la santé (Inpes) Vaccinations : attitudes et pratiques des médecins généralistes. Etudes Résultats -Panel Obs Prat Cond Exerc En Médecine Générale, 0910.

M. Available-from-mergler, S. Omer, W. Pan, A. Navar-boggan, W. Orenstein et al., Association of vaccine-related attitudes and beliefs between parents and health care providers. Vaccine, pp.4591-4596, 2013.

M. France, 18 000 morts de la grippe cet hiver : il faut changer de politique [Internet]. 2015 Available from: http://www.mgfrance.org/index.php/presse/communiques/859-18-000-morts-de-la- grippe-cet-hiver-il-faut-changer-de-politique 74. Pica N, Palese P. Toward a universal influenza virus vaccine: prospects and challenges, Annu Rev Med, vol.64, pp.189-202, 2013.

J. S. Bresee, M. , T. M. Uyeki, and M. , Antiviral Agents for the Treatment and Chemoprophylaxis of Influenza.pdf. MMWR: Morbidity & Mortality Weekly Report, 2011.

A. Monto, M. Pichichero, S. Blanckenberg, O. Ruuskanen, C. Cooper et al., Zanamivir Prophylaxis: An Effective Strategy for the Prevention of Influenza Types A and B within Households, The Journal of Infectious Diseases, vol.186, issue.11, pp.1582-1590, 2002.
DOI : 10.1086/345722

F. Hayden, R. Atmar, M. Schilling, C. Johnson, D. Poretz et al., Use of the Selective Oral Neuraminidase Inhibitor Oseltamivir to Prevent Influenza, New England Journal of Medicine, vol.341, issue.18
DOI : 10.1056/NEJM199910283411802

A. Kumar, Early versus late oseltamivir treatment in severely ill patients with 101

J. Louie, M. Acosta, K. Winter, C. Jean, S. Gavali et al., Factors Associated With Death or Hospitalization Due to Pandemic 2009 Influenza A(H1N1) Infection in California, JAMA, vol.302, issue.17, pp.1896-902, 2009.
DOI : 10.1001/jama.2009.1583

B. Mcquade and M. Blair, Influenza treatment with oseltamivir outside of labeled recommendations. Am J Health-Syst Pharm AJHP Off J Am Soc Health-Syst Pharm, 2015.

T. Blanchon, F. Geffrier, C. Turbelin, I. Daviaud, C. Laouénan et al., Use of neuraminidase inhibitors in primary health care during pandemic and seasonal influenza between 2009 and 2013. Antivir Ther Use of influenza antiviral agents by ambulatory care clinicians during the 2012-2013 influenza season, Feb Clin Infect Dis Off Publ Infect Dis Soc Am, vol.1759, issue.846, pp.774-82, 2014.
URL : https://hal.archives-ouvertes.fr/inserm-01242944

M. Lindegren and W. Schaffner, Treatment With Neuraminidase Inhibitors for

P. Peters, A. Moscona, K. Schulman, and C. Barr, Study of the impact of oseltamivir on the risk for pneumonia and other outcomes of influenza, Medscape J Med, vol.10, issue.6, p.131, 2000.

J. Hernandez, J. Grainger, L. Simonsen, P. Collis, L. Edelman et al., influenza A (H1N1) pandemic on trends in influenza hospitalization, diagnostic testing, and treatment. Influenza Other Respir Viruses, pp.305-313, 2009.

L. Williams, N. Kupka, S. Schmaltz, S. Barrett, T. Uyeki et al., Rapid influenza diagnostic test use and antiviral prescriptions in outpatient settings pre- and post-2009 H1N1 pandemic, Centers for Disease Control and Prevention. Guidance for Clinicians on the Use of Rapid Influenza Diagnostic Tests -Seasonal influenza [Internet]. 2014. Available from, pp.27-33, 2014.
DOI : 10.1016/j.jcv.2014.01.016